Publications by authors named "J M Kamal"
Introduction: The use of therapeutic apheresis (TA) either as stand-alone or adjunctive treatment in kidney transplantation has increased over the years to become a leading indication. This study shows recent trends in indications for TA related to kidney transplantation, adverse events, and patient outcome in this cohort.
Methods: This is a retrospective cohort review of adults who received TA for kidney transplant-related indications from January 1, 2017, to December 31, 2022, at the University of Virginia Medical Centre, Charlottesville, VA, USA.
Esthetic Clinic Management Software-Can we improve patient safety?
J Plast Reconstr Aesthet Surg
January 2024
Aim: To evaluate the features of esthetic-specific Clinic Management Softwares (CMS) and scrutinize these against the General Medical Council (GMC) and Joint Commission (JC) guidance, an indicative CMS framework with GMC and JC compliant features is developed, to improve patient outcomes, service quality, and work toward a centralized database for complications to enable research analysis.
Methods: A systematic search was performed to evaluate the CMS on the market tailored to esthetic clinics. An analysis was made of the GMC guidance for record keeping and the JC standards for Patient Safety Systems.
Background: Maintaining the quality of life is the main objective of managing type 2 diabetes (T2DM) (QoL). Since it is a key factor in patient motivation and adherence, treatment-related QoL has always been considered when choosing glucose-lowering medicines. The objective of the study was to evaluate the quality of life besides glycemic control among type 2 diabetes mellitus patients receiving Treviamet® & Treviamet XR® (Sitagliptin with Metformin) in routine care.
View Article and Find Full Text PDFThe emergence of robotics in surgery has led to a recent boom in the acceptance of such technology. This technology has been rapidly adopted in various fields, with the most prominent being general surgery. The number of abdominal procedures being performed using robotics has increased to around 15.
View Article and Find Full Text PDFArticle Synopsis
- IgA nephropathy (IgAN) is a common kidney disease that can recur after transplantation, but its causes and outcomes are not well understood, prompting this study on the influence of HLA antigens.
- The study analyzed 282 kidney transplant patients, noting that those with IgAN had different HLA antigen frequencies compared to healthy controls, but recurrent IgAN patients had similar frequencies to non-recurrent ones.
- Younger age at transplantation and HLA-matching in living-related donors were linked to recurrent IgAN, which significantly worsened allograft survival alongside other factors like acute rejection and higher serum creatinine levels.